Literature DB >> 31541282

Adult-onset Still's disease with macrophage activation syndrome diagnosed and treated based on cytokine profiling: a case-based review.

Ken Goda1,2, Tsuneaki Kenzaka3,4, Masahiko Hoshijima1, Akihiro Yachie5, Hozuka Akita1.   

Abstract

Adult-onset Still's disease (AOSD) is a relatively rare systemic inflammatory disorder and is diagnosed using various sets of classification criteria, with the Yamaguchi criteria as the most widely used criteria. Herein, we present the case of a 21-year-old woman admitted with a high fever, lasting for over 1 month, who did not fulfill the Yamaguchi criteria. However, by analyzing the inflammatory cytokine profile, we defined this case as AOSD based on a greatly elevated serum interleukin-18 level. In addition, we predicted the occurrence of macrophage activation syndrome by a characteristic increase in the soluble tumor necrosis factor receptor II level, which allowed a timely intervention for this malicious complication. Therefore, we suggest that cytokine profiling will be useful for the diagnosis and management of AOSD.

Entities:  

Keywords:  Adult-onset still’s disease; Cytokines; Diagnosis; Macrophage activation syndrome

Mesh:

Substances:

Year:  2019        PMID: 31541282     DOI: 10.1007/s00296-019-04446-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  18 in total

1.  Adult Still's disease reflects a Th2 rather than a Th1 cytokine profile.

Authors:  Osamu Saiki; Hiroshi Uda; Norihiko Nishimoto; Takashi Miwa; Toru Mima; Tomoharu Ogawara; Naoto Azuma; Yoshinori Katada; Junko Sawaki; Hiroko Tsutsui; Kiyoshi Matsui; Akira Maeda; Kenji Nakanishi
Journal:  Clin Immunol       Date:  2004-07       Impact factor: 3.969

2.  Clinical features of macrophage activation syndrome in the adult northern Chinese population.

Authors:  X Li; B Qu; Y Nie; G Zhu; W Li; F Mu
Journal:  Lupus       Date:  2014-03-28       Impact factor: 2.911

3.  Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease.

Authors:  Der-Yuan Chen; Joung-Liang Lan; Fang-Ju Lin; Tsu-Yi Hsieh
Journal:  J Rheumatol       Date:  2004-11       Impact factor: 4.666

4.  Correlation of serum CX3CL1 level with disease activity in adult-onset Still's disease and significant involvement in hemophagocytic syndrome.

Authors:  Tsuyoshi Kasama; Hidekazu Furuya; Ryo Yanai; Kumiko Ohtsuka; Ryo Takahashi; Nobuyuki Yajima; Yusuke Miwa; Kazuo Kobayashi
Journal:  Clin Rheumatol       Date:  2012-02-10       Impact factor: 2.980

Review 5.  Adult-onset Still's disease.

Authors:  Valentina Bagnari; Matteo Colina; Giovanni Ciancio; Marcello Govoni; Francesco Trotta
Journal:  Rheumatol Int       Date:  2009-12-18       Impact factor: 3.580

Review 6.  Comparative study of 6 types of criteria in adult Still's disease.

Authors:  C Masson; X Le Loet; F Liote; J J Dubost; M C Boissier; L Perroux-Goumy; C Bregeon; M Audran
Journal:  J Rheumatol       Date:  1996-03       Impact factor: 4.666

7.  Cytokine profile in adult-onset Still's disease: Comparison with systemic juvenile idiopathic arthritis.

Authors:  Natsumi Inoue; Masaki Shimizu; Shinichiro Tsunoda; Mitsuhiro Kawano; Masami Matsumura; Akihiro Yachie
Journal:  Clin Immunol       Date:  2016-06-03       Impact factor: 3.969

Review 8.  Macrophage activation syndrome.

Authors:  Angelo Ravelli
Journal:  Curr Opin Rheumatol       Date:  2002-09       Impact factor: 5.006

9.  Serum IL-18 as biomarker in predicting long-term renal outcome among pediatric-onset systemic lupus erythematosus patients.

Authors:  Chao-Yi Wu; Huang-Yu Yang; Tsung-Chieh Yao; Su-Hsun Liu; Jing-Long Huang
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

Review 10.  Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence.

Authors:  Hubert de Boysson; Jérome Février; Amélie Nicolle; Christophe Auzary; Loïk Geffray
Journal:  Clin Rheumatol       Date:  2012-10-30       Impact factor: 3.650

View more
  2 in total

Review 1.  Myocarditis in Adult-Onset Still's Disease: Case-Based Review.

Authors:  Abraham Edgar Gracia-Ramos; Joshua Antonio Contreras-Ortíz
Journal:  Clin Rheumatol       Date:  2019-11-20       Impact factor: 3.650

2.  Elevated serum levels of checkpoint molecules in patients with adult Still's disease.

Authors:  Yuya Fujita; Tomoyuki Asano; Haruki Matsumoto; Naoki Matsuoka; Jumpei Temmoku; Shuzo Sato; Makiko Yashiro Furuya; Eiji Suzuki; Hiroshi Watanabe; Tomohiro Koga; Atsushi Kawakami; Kiyoshi Migita
Journal:  Arthritis Res Ther       Date:  2020-07-22       Impact factor: 5.156

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.